Article Details
Retrieved on: 2020-12-04 14:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In the 68-patient Pinta trial, patients were given GLPG1205 on top of either Boehringer's Ofev or <b>Roche's</b> Esbriet, the two currently approved IPF drugs.
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here